Author

David J. McConkey

Observed names: David J. Mcconkey, David James McConkey, David McConkey

Institutions: Johns Hopkins University, Johns Hopkins Medicine, University of Rochester Medicine, Johns Hopkins Hospital, University of Rochester

Observed institutions: Johns Hopkins University, Johns Hopkins Medicine, University of Rochester Medicine, Johns Hopkins Hospital, University of Rochester

OpenAlex ID: A5139960538

Integrated Urine and Plasma DNA Analysis for Molecular Staging of Upper Tract Urothelial Carcinoma

2026 · Maximilian Pallauf, Stephan Bronimann, et al. · European Urology Oncology

Impact of divergent differentiation and histological subtypes on oncologic outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma

2026 · Maximilian Pallauf, Stephan Brönimann, et al. · Urologic Oncology Seminars and Original Investigations

Combination treatment with intravesical interferon-alpha gene therapy and an oral pan-ErbB receptor family blocker improves survival in mice with bladder cancer

2026 · Akshay Sood, Alberto Martini, et al. · Frontiers in Molecular Biosciences

Integrating clinically actionable biomarkers into bladder cancer care — recommendations from the International Bladder Cancer Group

2026 · Patrick J. Hensley, Jeremy Y. C. Teoh, et al. · Nature Reviews Urology

Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner

2026 · Aymeric Zadoroznyj, Pontus Eriksson, et al. · npj Precision Oncology

Abstract 5931: Modeling of bladder cancer evolution from field effects by multi-platform spatial mapping on the whole-organ scale

2026 · Bogdan A. Czerniak, Sangkyou Lee, et al. · Cancer Research

SWOG 2427: Single arm phase II study of bladder preservation with immunoradiotherapy after a clinically meaningful response to neoadjuvant therapy in patients with muscle invasive bladder cancer (BRIGHT).

2026 · Leslie K. Ballas, Samuel Callis, et al. · Journal of Clinical Oncology

Combination Treatment with Intravesical Interferon-Alpha Gene Therapy and Oral Pan-ErbB Receptor Family Blocker Improves Survival in Mice with Bladder Cancer

2026 · Akshay Sood, Alberto Martini, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Works count: 12

Citation count:

H-index:

I10-index: